SUBPART C—Index of Legally Marketed Unapproved New Animal Drugs for Minor Species (§516.111 to §516.171)
- 516.111—Scope of this subpart.
- 516.115—Definitions.
- 516.117—Submission of correspondence under this subpart.
- 516.119—Permanent-resident U.S. agent for foreign requestors and holders.
- 516.121—Meetings.
- 516.123—Informal conferences regarding agency administrative actions.
- 516.125—Investigational use of minor species new animal drugs to support indexing.
- 516.129—Content and format of a request for determination of eligibility for indexing.
- 516.131—Refuse to file a request for determination of eligibility for indexing.
- 516.133—Denying a request for determination of eligibility for indexing.
- 516.135—Granting a request for determination of eligibility for indexing.
- 516.137—Notification of decision regarding eligibility for indexing.
- 516.141—Qualified expert panels.
- 516.143—Written report.
- 516.145—Content and format of a request for addition to the index.
- 516.147—Refuse to file a request for addition to the index.
- 516.149—Denying a request for addition to the index.
- 516.151—Granting a request for addition to the index.
- 516.153—Notification of decision regarding index listing.
- 516.155—Labeling of indexed drugs.
- 516.157—Publication of the index and content of an index listing.
- 516.161—Modifications to indexed drugs.
- 516.163—Change in ownership of an index file.
- 516.165—Records and reports.
- 516.167—Removal from the index.
- 516.171—Confidentiality of data and information in an index file.